01b: Steroid Hormone Synthesis Flashcards
List the five classes of steroid hormones.
- Glucocorticoids
- Mineralocorticoids
- Androgens
- Estrogens
- Progesterone
There are (X) classes of steroid hormones, which can be categorized/grouped into either (Y) or (Z).
X = 5 Y = corticosteroids Z = sex steroids
Sex steroid hormones are made from (X) and corticosteroids are made from (Y).
X = Y = cholesterol (all steroid hormones are)
Which symptom on a skin exam would be significant clue of a steroid hormone problem?
Hyperpigmentation
You suspect presence of steroid hormone problem in your patient. What would you do next? Be specific.
Order tests to examine levels of different steroid hormones and their precursors
The first step in steroid hormone synthesis is universally (X) conversion to (Y) via (Z) enzyme.
X = cholesterol Y = pregnenolone Z = desmolase
Steroid hormone synthesis begins in (cytoplasm/ER/mito), specifically in (X).
Mitochondria;
X = IMM
StAR is crucial for:
Cholesterol entry into mitochondria
T/F: A mutation that makes StAR completely dysfunctional is one that’s incompatible with life.
True
What’s the rate-limiting step in cortisol biosynthesis?
Cholesterol transport into mito by StAR (rate-limiting for synthesis of ALL steroid hormones)
Cortisol synthesis: Prognenolone is converted into (X) via (Y) enzyme. Where does this occur?
X = progesterone Y = 3-beta-hydroxy steroid DH
Cytoplasm
T/F: Once progesterone is formed in cortisol biosynthesis, it moves out from mito into cytoplasm.
False - it’s formed in cytoplasm (pregnenolone moves out prior to progesterone formation)
Cortisol synthesis: Progesterone is converted into (X) via (Y) enzyme. Where does this occur?
X = 17-alpha-hydroxyprogesterone Y = 17-alpha-hydroxylase
ER
Cortisol synthesis: there are two paths that can be taken to arrive at (X) intermediate from (Y).
X = 17-alpha-hydroxyprogesterone Y = pregnenolone
Pregnenolone can be acted on by which two enzymes in steroid hormone biosynthesis? List the respective product of each.
- 3-beta-hydroxy steroid DH (progesterone)
2. 17-alpha-hydroxylase (17-alpha-hydroxypregnenolone)
Cortisol synthesis: 17-alpha-hydroxyprogesterone is converted into (X) via (Y) enzyme.
X = 11-deoxycortisol Y = 21-alpha-hydroxylase
The final (1/2/3) step(s) of cortisol biosynthesis occur in mitochondria. Which intermediate makes the trip back there?
1;
11-deoxycortisol
Cortisol synthesis: 11-deoxycortisol is converted into (X) via (Y) enzyme.
X = Cortisol Y = 11-beta-hydroxylase
In (X) steroid synthesis pathway, 17-alpha-hydroxylase acts twice. If its first reactant is pregnenolone, which two products are formed?
X = androgen
- 17-alpha-hydroxypregnenolone
- DHEA
DHEA is an important intermediate in (X) steroid biosynthesis. (Y) enzyme acts on it to produce (Z) product.
X = androgen Y = 3-beta-hydroxy steroid DH Z = Androstenedione
Testosterone is formed directly from (X) via (Y) enzyme.
X = Androstenedione Y = 17-beta-hydroxy steroid DH
(X) intermediate can be acted in by either (Y) enzyme to form testosterone or (Z) enzyme to form:
X = androstenedione Y = testosterone Z = aromatase
Estrone
Testosterone, if acted on by (X) enzyme, will form (Y).
X = aromatase Y = estradiol
(X) intermediate in androgen synthesis can be formed from either (Y) intermediate or from the cortisol synthesis intermediate, (Z). Which enzymes involved in each path?
X = androstenedione Y = DHEA (3-beta-hydroxy steroid DH) Z = 17-alpha-hydroxyprogesterone (17-alpha-hydroxylase)
T/F: Aldosterone can be an intermediate in one pathway for testosterone biosynthesis.
False
T/F: Path for Aldosterone biosynthesis, like that for androgen synthesis, branches off at the pregnenolone step.
False - at progesterone step
Aldosterone synthesis: Progesterone becomes (X) when acted on by (Y) enzyme.
X = 11-deoxycorticosterone Y = 21-alpha-hydroxylase
Aldosterone synthesis: 11-deoxycorticosterone becomes (X) when acted on by (Y) enzyme.
X = corticosterone Y = 11-beta-hydroxylase
Corticosterone is an intermediate in (X) steroid hormone biosynthesis. It becomes (Y) when acted on by (Z) hormone.
X = Y = aldosterone Z = aldosterone synthase
Synthesis of aldosterone occurs in which gland?
Zona glomerulosa of adrenal cortex
Testosterone primarily produced in (X), but its synthesis also occurs in which gland?
X = testes
Zona reticularis of adrenal cortex
Cortisol synthesis occurs in which gland?
Zona fasciculata of adrenal cortex
Synthesis of (X) occurs in response to ACTH, aka (Y), release from (Z).
X = cortisol Y = Adrenocorticotropic hormone Z = anterior pituitary gland
The two key steps that make up the delta-4 and delta-5 pathways of (X) synthesis are essentially carrying out which functions? What’s the difference between the pathways?
X = androgen
Hydroxylation, then lyase activity (BOTH via 17-alpha-hydroxylase);
Starting at different intermediates (either pregnenolone or progesterone)
Delta-(4/5) pathway tends to dominate. In the two key steps of this pathway, (hydroxylation/lyase) of (X) is followed by (hydroxylation/lyase) of (Y).
Delta-5; Hydroxylation; X = pregnenolone Lyase; Y = 17-alpha-hydroxypregnenolone
Metabolism of testosterone: in (X) tissue/organ, testosterone is metabolized to (Y) by (Z) enzyme.
X = any of its target Y = DHT (dihydrotestosterone) Z = 5-alpha-reductase
One treatment for BPH (benign prostatic hyperplasia) is (X), which will (stimulate/inhibit) metabolism of (Y).
X = 5-alpha-reductase inhibitors;
Inhibit;
Y = testosterone
T/F: Estrogens are made from androgens.
True
Esterogen receptor is located in (X) compartment of cell and associated with (Y) protein when inactivated.
X = cytoplasm Y = HSP90
Estrogen Receptor: When (X) enters cell, it displaces (Y) and binds estrogen receptor. The complex moves to (Z) compartment as (monomer/dimer/trimer/other).
X = estradiol Y = HSP90 Z = nucleus
Monomer (dimerizes inside nucleus)
Estrogen receptor: the H-R complex binds to (X) of DNA. In absence of ligand, can estrogen receptor bind DNA?
X = ERE (esterogen response element)
No
Prostate cancer can be treated by (agonist/antagonist) to (X) receptor.
Antagonist;
X = Androgen
One method of contraception is an (agonist/antagonist) to (X) receptor.
Antagonist;
X = Progesterone
You’d expect an aldosterone receptor antagonist to be treatment for which array of symptoms/diseases?
- Edema
- Hypokalemia
- CHF, HT
A deficiency in (X) enzyme of steroid hormone biosynthesis would cause patient to have virtually no steroid hormones and (male/female)-like genitalia.
X = 3-beta-hydroxy steroid DH
Female
A deficiency in (X) enzyme of steroid hormone biosynthesis would cause patient to have virtually no sex hormones or cortisol and (male/female)-like genitalia. You’d expect (over/under)-production of mineralocorticoids and which symptoms?
X = 17-alpha-hydroxylase
Female;
Over-production;
Na/fluid retention and HT
A deficiency in (X) enzyme of steroid hormone biosynthesis would cause patient to have virtually no mineralocorticosteroids and glucocorticoids and (male/female)-like genitalia.
X = 21-alpha-hydroxylase
Masculinization of external F genitalia and early virilization in M
A deficiency in (X) enzyme of steroid hormone biosynthesis would cause patient to have decreased serum cortisol, aldosterone, and corticosterone and (male/female)-like genitalia. There’s be an increased production of which specific intermediate?
X = 11-beta-hydroxylase;
Masculinization of external F genitalia and early virilization in M;
Deoxycorticosterone (fluid retention)
Deficiency in which steroid hormone synthesis enzymes would cause fluid retention/edema?
- 17-alpha-hydroxylase
2. 11-beta-hydroxylase
Deficiency in which steroid hormone synthesis enzymes is most common?
21-alpha-hydroxylase (over 90%)
Tamoxifen is a drug used to treat (X). What’s its general mechanism of action?
X = some types of breast cancer
Binds estrogen receptor (prevents estrogen from binding and inducing conformational change); prevents its association with co-activators
Tamoxifen, though a drug that blocks (X) in breast cell, may be a cause for (Y) because it (activates/inhibits) (Z).
X = estrogen receptor
Y = uterine cancer;
Activates
Z = estrogen receptor in uterus (endometrial proliferation)
Instead of blocking the estrogen receptor, some FDA drugs decrease effect of estrogens via:
Inhibiting aromatase (preventing estrogen production in first place)